Previous Close | 68.16 |
Open | 68.04 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's Range | 66.86 - 68.64 |
52 Week Range | 25.11 - 72.18 |
Volume | |
Avg. Volume | 573,117 |
Market Cap | 4.953B |
Beta (5Y Monthly) | 1.74 |
PE Ratio (TTM) | 372.06 |
EPS (TTM) | 0.18 |
Earnings Date | Nov 06, 2024 - Nov 11, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 77.33 |
PACB partners with NCCS to enhance cancer research using the Onso short-read platform and Revio long-read sequencing, advancing precision oncology in Singapore and Asia.
RadNet Inc (RDNT) reports a 13.9% revenue increase and strategic acquisitions, despite facing net loss and labor cost challenges.
RadNet (RDNT) possesses solid growth attributes, which could help it handily outperform the market.